Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.54 - $2.09 $39,739 - $53,932
25,805 New
25,805 $49,000
Q3 2023

Nov 09, 2023

BUY
$2.18 - $5.52 $11,957 - $30,277
5,485 Added 27.25%
25,611 $56,000
Q2 2023

Aug 14, 2023

SELL
$3.16 - $4.96 $49,393 - $77,529
-15,631 Reduced 43.71%
20,126 $85,000
Q1 2023

May 15, 2023

BUY
$3.6 - $5.88 $48,668 - $79,491
13,519 Added 60.79%
35,757 $138,000
Q4 2022

Feb 13, 2023

BUY
$5.03 - $8.58 $6,508 - $11,102
1,294 Added 6.18%
22,238 $128,000
Q3 2022

Nov 14, 2022

SELL
$7.7 - $13.31 $54,762 - $94,660
-7,112 Reduced 25.35%
20,944 $162,000
Q2 2022

Aug 11, 2022

BUY
$6.72 - $16.07 $20,845 - $49,849
3,102 Added 12.43%
28,056 $251,000
Q1 2022

May 13, 2022

SELL
$11.88 - $23.4 $29,901 - $58,897
-2,517 Reduced 9.16%
24,954 $381,000
Q4 2021

Feb 11, 2022

SELL
$21.08 - $38.51 $429,062 - $783,832
-20,354 Reduced 42.56%
27,471 $626,000
Q3 2021

Nov 04, 2021

BUY
$27.67 - $45.04 $1.07 Million - $1.73 Million
38,513 Added 413.58%
47,825 $1.65 Million
Q2 2021

Aug 11, 2021

SELL
$28.75 - $56.92 $8,768 - $17,360
-305 Reduced 3.17%
9,312 $306,000
Q1 2021

May 13, 2021

BUY
$38.67 - $84.06 $371,889 - $808,405
9,617 New
9,617 $481,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $135M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.